Cancer nanotherapeutics, extracellular vesicles, biosensors, cancer liquid biopsy

• September 2022–August 2027
  Lung cancer early detection and immunotherapy response prediction and monitoring with an Exo-PROS liquid biopsy assay
  NCI
  Role: Principal Investigator
  $3,120,685
• April 2023–March 2027
  Multifunctional Biodegradable Zwitterionic Polymer-Drug Conjugates for Multidrug
  NIBIB
  Role: Co-Investigator
  $2,388,081
• July 2022–June 2024
  Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection
  NCI
  Role: Principal Investigator
  $431,992
• August 2020–July 2023
  An inflammation-induced fibrosis-on-chip system for the testing of anti-fibrosis drugs
  NHLBI
  Role: Co-Investigator
  $920,000
• September 2021–June 2023
  Zwitterionic dendrimer-modified PEG for protein conjugation
  NIBIB
  Role: Co-Principal Investigator
  $433,902
• March 2019–February 2023
  Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection
  NCI
  Role: Principal Investigator
  $565,427
• September 2019–August 2022
  Exosome Protein microRNA One Stop (Exo-PROS) biosensor: a new liquid biopsy for precision cancer immunotherpay
  Cancer Research Institute
  Role: Principal Investigator
  $200,000
• September 2017–February 2022
  PFI: BIC: WearNet: Smart Health Monitoring & Diagnosis System Based on Wearable Nano-biosensing Networks
  NSF
  Role: Co-Principal Investigator
  $1,047,141
• October 2019–December 2021
  Development of Tumor Targeted Nanoparticles to Combat EGFR TKI Resistance
  American Lung Association
  Role: Co-Principal Investigator
  $200,000
• September 2015–August 2021
  Noninvasive Detection of Circulating RNAs for Lung Cancer Early Detection and Prognosis
  NCI
  Role: Principal Investigator
  $1,279,946